CP-547632   Click here for help

GtoPdb Ligand ID: 7881

Synonyms: CP 547,632 | CP 547632 | CP-547,632 | CP547632
PDB Ligand
Compound class: Synthetic organic
Comment: CP-547632 is a potent inhibitor of VEGFR2 and basic fibroblast growth factor (FGF) receptor kinases [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 12
Topological polar surface area 137.82
Molecular weight 531.08
XLogP 3.27
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(Nc1snc(c1C(=O)N)OCc1c(F)cc(cc1F)Br)NCCCCN1CCCC1
Isomeric SMILES O=C(Nc1snc(c1C(=O)N)OCc1c(F)cc(cc1F)Br)NCCCCN1CCCC1
InChI InChI=1S/C20H24BrF2N5O3S/c21-12-9-14(22)13(15(23)10-12)11-31-18-16(17(24)29)19(32-27-18)26-20(30)25-5-1-2-6-28-7-3-4-8-28/h9-10H,1-8,11H2,(H2,24,29)(H2,25,26,30)
InChI Key HXHAJRMTJXHJJZ-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
CP-547632 is a well-tolerated, orally-bioavailable VEGFR2 inhibitor investigated for the treatment of human malignancies. Two Phase 2 clinical trials NCT00096239 and NCT00074867 for recurrent or persistent ovarian cancer, primary peritoneal cancer, or fallopian tube cancer have been completed. There are no active trials for CP-547632 (Nov 2014).